Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Acetylcholine Receptor Subunit alpha (CHRNA1) Peptide

CHRNA1 Reactivity: Human, Mouse Host: Synthetic BP, WB
Catalog No. ABIN974945

Quick Overview for Acetylcholine Receptor Subunit alpha (CHRNA1) Peptide (ABIN974945)

Target

CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))

Origin

Human, Mouse

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-CHRNA1 antibody (Catalog #: ARP34909_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))

    Background

    The muscle acetylcholine receptor consiststs of 5 subunits of 4 different types: 2 alpha isoforms and 1 each of beta, gamma, and delta subunits.2 CHRNA1 encodes an alpha subunit that plays a role in acetlycholine binding/channel gating.

    Alias Symbols: ACHRA, ACHRD, CHRNA, CMS2A, FCCMS, SCCMS

    Protein Interaction Partner: CHRND,CHRNE,CHRNG,ITGA7,CHRND,CHRNE,CHRNG,ITGA7

    Protein Size: 457

    Molecular Weight

    52 kDa

    Gene ID

    1134

    NCBI Accession

    NM_000079, NP_000070
You are here:
Chat with us!